2022 American Transplant Congress » Late Breaking: Clinical
Date: Sunday, June 5, 2022
Time: 3:30pm-5:00pm
Location: Hynes Room 313
Session Type: Rapid Fire Oral Abstract
Meeting: 2022 American Transplant Congress
- 3:30pm-3:40pm
Establishment And Validation Of A Predictive Model For Differential Rejection Diagnosis By Gene Expression Profiling (GEP) In Renal Allograft Biopsies Using Banff Human Organ Transplant (B-HOT) Gene Panel
H. Zhang1, R. Haun2, F. Collin1, C. Cassol2, S. Coley2, J. Wilson2, S. Stone1, K. Qu1, W. Tian1, N. Agrawal1, G. Shekhtman1, C. Larsen2
- 3:40pm-3:50pm
Phase I/ii Car-Treg Cell Therapy Clinical Trial To Induce Long-term Tolerance In Liver Transplant Patients
A. Sanchez-Fueyo1, A. Taylor1, D. Collin2, C. Nathalie2, S. Chris2, M. Martinez-Llordella2, N. Belmonte2, I. McGill2, D. Hartl2
- 3:50pm-4:00pm
2021 Outcomes Analysis Of U.S. Transplant Centers Performing High Volumes Of Hard To Place Kidneys
D. Bahl1, A. Mahajan2, M. Smogorzewski3, Y. A. Qazi4
- 4:00pm-4:10pm
Donor Organ Utilization And Transplantation Outcomes In Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion
M. Urban, S. Merani, N. W. Markin, A. Castleberry, J. Um
- 4:10pm-4:20pm
The Post-operative Clinical Outcomes Of 59 Tanrp Cases In An International Cohort
J. Louca1, N. Patel1, S. Messer2, J. Chindu2, S. Large2
- 4:20pm-4:30pm
Healthcare Cost And Kidney Allocation In Liver Recipients With Kidney Disease
Y. Lu1, X. Cheng2, S. Sanoff3, L. McElroy3
- 4:30pm-4:40pm
Early Clinical Experience With Nirmatrelvir/ritonavir For Treatment Of Covid-19 In Solid Organ Transplant Recipients
D. Salerno1, D. Jennings2, N. Lange3, D. Kovac1, T. Shertel1, J. Chen4, J. Hedvat5, J. Scheffert1, R. S. Brown6, M. Pereira7
- 4:40pm-4:50pm
130 Totally Robotic Donor Hepatectomy: Reproducibility Of A Standardized Technique Across 2 Specialized Centers
Y. Cheah1, H. Yang2, C. J. Simon1, J. Kim3, M. Akoad3, G. Choi2
- 4:50pm-5:00pm
Renal Transplants In Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Using Two Weeks Of DAA Prophylaxis (Rehanna – 2)
N. M. Desai1, S. Leung1, J. Motter1, F. Naqvi2, N. Bair1, B. Barnaba2, D. Warren1, D. Segev1, C. Durand2
« View all sessions from the 2022 American Transplant Congress